The onset of substance use mostly occurs during adolescence. The aim of the present study is to investigate the relevance of personality on the basis of the NEO-Five-Factor Inventory (NEO-FFI) to future experiences with tobacco, alcohol and cannabis.
The test data were derived from the baseline assessment and first follow-up of the IMAGEN study, a European multicenter and multidisciplinary research project on adolescent mental health. In the present study 1004 participants were tested. The characterization of personality was conducted with the NEO-FFI at the age of 14 (T1). The data on substance use were collected with the European School Survey Project on Alcohol and Other Drugs (ESPAD) questionnaire at the age of 16 (T2). For the statistical analysis, t-tests and univariate analyses of variance were performed.
The scores of Conscientiousness at T1 were significantly lower for adolescents with tobacco, alcohol and cannabis experiences at T2. We found lower scores of Agreeableness at T1 in participants with tobacco and cannabis use at T2. Extraversion at T1 was significantly higher for adolescents with smoking experiences at T2. No significant associations between Neuroticism or Openness and future substance use were observed.
Low scores of Conscientiousness and Agreeableness seem to have the greatest value for a prediction of later experiences with substance use. As the present study is the first one to examine the predictive value of the NEO-FFI for future substance use in an adolescent sample, further studies are necessary to enable a better applicability in a clinical context.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Battistella G, Fornari E, Annoni JM, Chtioui H, Dao K, Fabritius M, Favrat B, Mall JF, Maeder P, Giroud C (2014) Long-term effects of cannabis on brain structure. Neuropsychopharmacology 39(9):2041–2048. doi:10.1038/npp.2014.67
Centers for Disease Control & Prevention (2008) Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004. MMWR Morb Mortal Wkly Rep 57(45):1226–1228
Clark A, Tran C, Weiss A, Caselli G, Nikcevic AV, Spada MM (2012) Personality and alcohol metacognitions as predictors of weekly levels of alcohol use in binge drinking university students. Addict Behav 37(4):537–540. doi:10.1016/j.addbeh.2011.11.035
De Sousa KR, Tiwari AK, Giuffra DE, Mackenzie B, Zai CC, Kennedy JL (2013) Age at onset of schizophrenia: cannabis, COMT gene, and their interactions. Schizophr Res 151(1–3):289–290. doi:10.1016/j.schres.2013.10.037
DeWit DJ, Adlaf EM, Offord DR, Ogborne AC (2000) Age at first alcohol use: a risk factor for the development of alcohol disorders. Am J Psychiatry 157(5):745–750
Dierker L, Selya A, Piasecki T, Rose J, Mermelstein R (2013) Alcohol problems as a signal for sensitivity to nicotine dependence and future smoking. Drug Alcohol Depend 132(3):688–693. doi:10.1016/j.drugalcdep.2013.03.018
Fridberg DJ, Vollmer JM, O’Donnell BF, Skosnik PD (2011) Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Res 186(1):46–52. doi:10.1016/j.psychres.2010.07.035
Gallinat J, Meisenzahl E, Jacobsen LK, Kalus P, Bierbrauer J, Kienast T, Witthaus H, Leopold K, Seifert F, Schubert F, Staedtgen M (2006) Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci 24(6):1744–1750. doi:10.1111/j.1460-9568.2006.05050.x
Grant JD, Scherrer JF, Lynskey MT, Lyons MJ, Eisen SA, Tsuang MT, True WR, Bucholz KK (2006) Adolescent alcohol use is a risk factor for adult alcohol and drug dependence: evidence from a twin design. Psychol Med 36(1):109–118. doi:10.1017/S0033291705006045
Hibell B, Andersson B, Ahlström S, Balakireva O, Bjarnason T, Kokkevi A, Morgan M (2000) The 1999 ESPAD report. Alcohol and other drug use among students in 30 European Countries. The Swedish Council for Information on Alcohol and Other Drugs, Stockholm
Hibell B, Andersson B, Bjarnason T, Ahlström S, Balakireva O, Kokkevi A, Morgan M (2004) The ESPAD report 2003. Alcohol and other drug use among students in 35 European countries. The Swedish Council for Information on Alcohol and Other Drugs, Stockholm
Hinckers AS, Laucht M, Schmidt MH, Mann KF, Schumann G, Schuckit MA, Heinz A (2006) Low level of response to alcohol as associated with serotonin transporter genotype and high alcohol intake in adolescents. Biol Psychiatry 60(3):282–287. doi:10.1016/j.biopsych.2005.12.009
Hyman SM, Sinha R (2009) Stress-related factors in cannabis use and misuse: implications for prevention and treatment. J Subst Abus Treat 36(4):400–413. doi:10.1016/j.jsat.2008.08.005
Kandel D, Yamaguchi K (1993) From beer to crack: developmental patterns of drug involvement. Am J Public Health 83(6):851–855
Kuhn S, Romanowski A, Schilling C, Mobascher A, Warbrick T, Winterer G, Gallinat J (2012) Brain grey matter deficits in smokers: focus on the cerebellum. Brain Struct Funct 217(2):517–522. doi:10.1007/s00429-011-0346-5
Malouff JM, Thorsteinsson EB, Rooke SE, Schutte NS (2007) Alcohol involvement and the Five-Factor model of personality: a meta-analysis. J Drug Educ 37(3):277–294
McCann SJ (2010) Subjective well-being, personality, demographic variables, and American state differences in smoking prevalence. Nicotine Tob Res 12(9):895–904. doi:10.1093/ntr/ntq113
McCrae RR, John OP (1992) An introduction to the five-factor model and its applications. J Pers 60(2):175–215
Pluess M, Bartley M (2015) Childhood conscientiousness predicts the social gradient of smoking in adulthood: a life course analysis. J Epidemiol Community Health 69(4):330–338. doi:10.1136/jech-2014-204263
Prescott CA, Kendler KS (2001) Early age at first alcoholic drink. Am J Psychiatry 158(9):1530
Salujha SK, Chaudhury S, Menon PK, Srivastava K, Gupta A (2014) Allelic variants of ADH, ALDH and the five factor model of personality in alcohol dependence syndrome. Ind Psychiatry J 23(1):44–51. doi:10.4103/0972-6748.144956
Schumann G, Loth E, Banaschewski T, Barbot A, Barker G, Buchel C, Conrod PJ, Dalley JW, Flor H, Gallinat J, Garavan H, Heinz A, Itterman B, Lathrop M, Mallik C, Mann K, Martinot JL, Paus T, Poline JB, Robbins TW, Rietschel M, Reed L, Smolka M, Spanagel R, Speiser C, Stephens DN, Strohle A, Struve M, and The IMAGEN consortium (2010) The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry 15(12):1128–1139. doi:10.1038/mp.2010.4
Vollrath ME, Torgersen S (2008) Personality types and risky health behaviors in Norwegian students. Scand J Psychol 49(3):287–292. doi:10.1111/j.1467-9450.2008.00631.x
Waga C, Iwahashi K (2007) CYP2A6 gene polymorphism and personality traits for NEO-FFI on the smoking behavior of youths. Drug Chem Toxicol 30(4):343–349. doi:10.1080/01480540701522338
Whelan R, Watts R, Orr CA, Althoff RR, Artiges E, Banaschewski T, Barker GJ, Bokde AL, Buchel C, Carvalho FM, Conrod PJ, Flor H, Fauth-Buhler M, Frouin V, Gallinat J, Gan G, Gowland P, Heinz A, Ittermann B, Lawrence C, Mann K, Martinot JL, Nees F, Ortiz N, Paillere-Martinot ML, Paus T, Pausova Z, Rietschel M, Robbins TW, Smolka MN, Strohle A, Schumann G, Garavan H, The IMAGEN consortium (2014) Neuropsychosocial profiles of current and future adolescent alcohol misusers. Nature 512(7513):185–189. doi:10.1038/nature13402
Woicik PA, Stewart SH, Pihl RO, Conrod PJ (2009) The Substance Use Risk Profile Scale: a scale measuring traits linked to reinforcement-specific substance use profiles. Addict Behav 34(12):1042–1055. doi:10.1016/j.addbeh.2009.07.001
Zvolensky MJ, Taha F, Bono A, Goodwin RD (2015) Big five personality factors and cigarette smoking: a 10-year study among US adults. J Psychiatr Res. doi:10.1016/j.jpsychires.2015.02.008
This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) (LSHM-CT- 2007–037286), the FP7 projects IMAGEMEND (602450; IMAgingGEnetics for MENtal Disorders) and MATRICS (603016), the Innovative Medicine Initiative Project EU-AIMS (115300–2), a Medical Research Council Programme Grant “Developmental pathways into adolescent substance abuse” (93558), the Swedish funding agency FORMAS, the Medical Research Council and the Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, the Bundesministerium für Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; eMED SysAlc01ZX1311A;Forschungsnetz AERIAL), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-1, SM 80/7-2, SFB 940/1) and the National Institutes of Health, USA (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1).
Conflict of interest
The authors declare no conflict of interest.
About this article
Cite this article
Parchetka, C., Strache, N., Raffaelli, B. et al. Predictive utility of the NEO-FFI for later substance experiences among 16-year-old adolescents. J Public Health 24, 489–495 (2016). https://doi.org/10.1007/s10389-016-0747-2
- Five-factor model of personality
- Substance use